C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/28 (2006.01) A61K 39/395 (2006.01) C12N 5/20 (2006.01) C12N 15/13 (2006.01) C12N 15/63 (2006.01) G01N 33/577 (2006.01)
Patent
CA 2618050
The invention relates to a monoclonal antibody directed against a human LDL (Low Density Lipoprotein) receptor bound to a corresponding peptide of 195-222 (SEQ ID NO: 1) amino acids of the LDL receptor peptide sequence, to the use thereof in the form of a drug, to a pharmaceutical composition containing said antibody and to the use thereof in immune-histochemical analysis of cancerous, healthy or cirrhosis-free or cirrhosis tissues in western blot, ELISA or in an in vivo quantification tests.
La présente invention concerne un anticorps monoclonal dirigé contre le récepteur humain des LDL (Low Density Lipoprotein), se liant au peptide correspondant aux acides aminés 280-307 (SEQ ID NO : 1) de la séquence peptidique du récepteur des LDL, son utilisation comme médicament, une composition pharmaceutique contenant cet anticorps, ainsi que son utilisation dans les analyses immunohistochimiques de tissus cancéreux, sains ou cirrhoses, en western blot, en ELISA ou en test de quantification in vivo.
Behrens Christian
Gaucher Christine
Najib Jamila
Prost Jean-Francois
Laboratoire Francais Du Fractionnement Et Des Biotechnologies Gr
Lfb Biotechnologies
Robic
LandOfFree
Antibodies directed against an ldl receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies directed against an ldl receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies directed against an ldl receptor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2048081